Cutting Edge: Identification of the Targets of Clonal Deletion in an Unmanipulated Thymus
2003; American Association of Immunologists; Volume: 170; Issue: 1 Linguagem: Inglês
10.4049/jimmunol.170.1.10
ISSN1550-6606
AutoresScott Cho, Samuel Edmondson, Arden D. Miller, MacLean Sellars, Shawn T. Alexander, Selin Somersan, Jennifer A. Punt,
Tópico(s)Whipple's Disease and Interleukins
ResumoAbstract Autoreactive thymocytes can be eliminated by clonal deletion during their development in the thymus. The precise developmental stage(s) at which clonal deletion occurs in a normal thymus has been difficult to assess, in large part because of the absence of a specific marker for TCR-mediated apoptosis. In this report, we reveal that Nur77 expression can be used as a specific marker of clonal deletion in an unmanipulated thymus and directly identify TCRintCD4+CD8+ and semimature CD4+CD8− thymocytes as the principal targets of deletion. These data indicate that clonal deletion normally occurs at a relatively late stage of development, as cells mature from CD4+CD8+ thymocytes to single-positive T cells.
Referência(s)